risedronic acid has been researched along with Alzheimer Disease in 4 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Neurological diseases, including Alzheimer's disease, stroke, and Parkinson's disease have been reported to increase the risk for fractures." | 2.44 | Efficacy of risedronate against hip fracture in patients with neurological diseases: a meta-analysis of randomized controlled trials. ( Iwamoto, J; Matsumoto, H; Takeda, T, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Schutter, JW | 1 |
| Park, J | 1 |
| Leung, CY | 1 |
| Gormley, P | 1 |
| Lin, YS | 1 |
| Hu, Z | 1 |
| Berghuis, AM | 1 |
| Poirier, J | 1 |
| Tsantrizos, YS | 1 |
| Sato, Y | 2 |
| Honda, Y | 2 |
| Iwamoto, J | 3 |
| Amano, N | 1 |
| Umeno, K | 1 |
| Hayashida, N | 1 |
| Takeda, T | 2 |
| Matsumoto, H | 2 |
1 review available for risedronic acid and Alzheimer Disease
| Article | Year |
|---|---|
Efficacy of risedronate against hip fracture in patients with neurological diseases: a meta-analysis of randomized controlled trials.
Topics: Age Distribution; Aged; Aged, 80 and over; Alzheimer Disease; Bone Density Conservation Agents; Conf | 2008 |
2 trials available for risedronic acid and Alzheimer Disease
| Article | Year |
|---|---|
Comparison of non-vertebral fracture between minodronate and risedronate therapy in elderly female patients with Alzheimer disease.
Topics: Accidental Falls; Aged; Alzheimer Disease; Body Mass Index; Bone Density; Bone Density Conservation | 2013 |
The prevention of hip fracture with menatetrenone and risedronate plus calcium supplementation in elderly patients with Alzheimer disease: a randomized controlled trial.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Bone Density; Bone Density Conservation Agents; Etidroni | 2011 |
1 other study available for risedronic acid and Alzheimer Disease
| Article | Year |
|---|---|
Multistage screening reveals chameleon ligands of the human farnesyl pyrophosphate synthase: implications to drug discovery for neurodegenerative diseases.
Topics: Allosteric Site; Alzheimer Disease; Catalytic Domain; Crystallography, X-Ray; Diphosphonates; Drug E | 2014 |